Atsushi Kato, PhDa, b, Whitney W. Stevens, MD,
PhDa, b, Bruce S. Bochner, MDa
a Department of Medicine, Division of Allergy and
Immunology, Northwestern University Feinberg School of Medicine,
Chicago, IL 60611, USA.
b Department of Otolaryngology, Northwestern
University Feinberg School of Medicine, Chicago, IL 60611, USA.
Word Count: 1004 words
Conflicts of interest: AK reports a consultant fee from Astellas Pharma
and a gift for his research from Lyra Therapeutics. WWS served on
advisory boards for GlaxoSmithKline, GenenTech, and Bristol Myers Squibb
and on a speaker’s bureau for GlaxoSmithKline. BSB receives
publication-related royalty payments from Elsevier and UpToDate. He
receives remuneration for consulting services (Glaxo SmithKline,
Sanofi/Regeneron) and for serving on the scientific advisory board of
Third Harmonic Bio, Inc. and Allakos, Inc. He also own stocks in
Allakos. BSB is a co-inventor on existing Siglec-8–related patents and
thus may be entitled to a share of royalties received by Johns Hopkins
University during development and potential sales of such products. BSB
is a co-founder of Allakos, Inc. which makes him subject to certain
restrictions under University policy. The terms of this arrangement are
being managed by Johns Hopkins University and Northwestern University in
accordance with their conflict of interest policies.
*Address correspondence to Atsushi Kato, Ph.D.,
Division of Allergy and Immunology, Northwestern University Feinberg
School of Medicine,
240 E. Huron, Room M304, Chicago, IL 60611 USA.
Phone: 312-503-0086, FAX: 312-503-0078, E-Mail:
a-kato@northwestern.edu